• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Product › Details

virostatic agent

	Next higher product group	anti-infective drug
	Status	1998-01-01 sales existent

Record changed: 2021-03-28

Advertisement

More documents for virostatic agent

• [1] Leyden Laboratories B.V.. (3/25/21). "Press Release: Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital". Ams...
• [2] Forbion Capital Partners. (1/19/21). "Press Release: Forbion Invests USD 2.3M in Seed Financing of CoviCept Therapeutics, Inc.". Naarden....
• [3] Gilead Sciences, Inc.. (12/10/20). "Press Release: Gilead Sciences to Acquire MYR GmbH". Foster City, CA & Bad Homburg....
• [4] Atea Pharmaceuticals, Inc.. (10/22/20). "Press Release: Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19". Boston, MA....
• [5] Exscientia Ltd.. (8/18/20). "Press Release: Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats". Brussels....
• [6] Saillant Therapeutics B.V.. (8/11/20). "Press Release: Dutch Saillant Therapeutics to Develop Generic Virus Inhibiting Therapy Based on Activation of a Cellular Master Regulator, Ending Virus Replication". Nijmegen....
• [7] MYR GmbH. (8/4/20). "Press Release: MYR Pharmaceuticals Receives Conditional Marketing Authorization by the European Commission for Hepcludex". Bad Homburg....
• [8] MYR GmbH. (6/10/20). "Press Release: MYR Pharmaceuticals Has Incorporated Its First European Subsidiary in France". Bad Homburg....
• [9] AiCuris Anti-infective Cures GmbH. (6/9/20). "Press Release: Royalty Pharma Acquires Partial Royalty Interest on Prevymis (Letermovir) from AiCuris Anti-infective Cures GmbH". New York, NY & Wuppertal....
• [10] Innovative Medicines Initiative (IMI). (5/12/20). "Press Release: IMI Announces COVID Projects, Boosts Funding Pot to EUR 72 million". Brussels....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.